Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China
Chen, Chenyang1,2; Luo, Fei1; Wu, Panyun1; Huang, Yiyuan1; Das, Avash3; Chen, Shenglan1; Chen, Jingyuan1; Hu, Xinqun1; Li, Fei4; Fang, Zhenfei1; Zhou, Shenhua1
通讯作者Fang, Zhenfei(fangzhenfei@csu.edu.cn) ; Zhou, Shenhua(zhoushenghua@csu.edu.cn)
2020-01-16
发表期刊JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
ISSN1582-1838
页码13
摘要The specific mechanism of pulmonary arterial hypertension (PAH) remains elusive. The present study aimed to explore the underlying mechanism of PAH through the identity of novel biomarkers for PAH using metabolomics approach. Serum samples from 40 patients with idiopathic PAH (IPAH), 20 patients with congenital heart disease-associated PAH (CHD-PAH) and 20 healthy controls were collected and analysed by ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry (UPLC-HRMS). Orthogonal partial least square-discriminate analysis (OPLS-DA) was applied to screen potential biomarkers. These results were validated in monocrotaline (MCT)-induced PAH rat model. The OPLS-DA model was successful in screening distinct metabolite signatures which distinguished IPAH and CHD-PAH patients from healthy controls, respectively (26 and 15 metabolites). Unbiased analysis from OPLS-DA identified 31 metabolites from PAH patients which were differentially regulated compared to the healthy controls. Our analysis showed dysregulation of the different metabolic pathways, including lipid metabolism, glucose metabolism, amino acid metabolism and phospholipid metabolism pathways in PAH patients compared to their healthy counterpart. Among these metabolites from dysregulated metabolic pathways, a panel of metabolites from lipid metabolism and fatty acid oxidation (lysophosphatidylcholine, phosphatidylcholine, perillic acid, palmitoleic acid, N-acetylcholine-D-sphingomyelin, oleic acid, palmitic acid and 2-Octenoylcarnitine metabolites) were found to have a close association with PAH. The results from the analysis of both real-time quantitative PCR and Western blot showed that expression of LDHA, CD36, FASN, PDK1 GLUT1 and CPT-1 in right heart/lung were significantly up-regulated in MCT group than the control group.
关键词lipid metabolism metabolomics pulmonary arterial hypertension
DOI10.1111/jcmm.14937
收录类别SCI ; SCI
语种英语
WOS记录号WOS:000507443300001
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/70455
专题植物化学与西部植物资源持续利用国家重点实验室
通讯作者Fang, Zhenfei; Zhou, Shenhua
作者单位1.Cent S Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha 410011, Hunan, Peoples R China
2.Cent S Univ, Xiangya Hosp 3, Dept Cardiovasc Med, Changsha, Peoples R China
3.Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX USA
4.Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China
推荐引用方式
GB/T 7714
Chen, Chenyang,Luo, Fei,Wu, Panyun,et al. Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,2020:13.
APA Chen, Chenyang.,Luo, Fei.,Wu, Panyun.,Huang, Yiyuan.,Das, Avash.,...&Zhou, Shenhua.(2020).Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE,13.
MLA Chen, Chenyang,et al."Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China".JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020):13.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chen, Chenyang]的文章
[Luo, Fei]的文章
[Wu, Panyun]的文章
百度学术
百度学术中相似的文章
[Chen, Chenyang]的文章
[Luo, Fei]的文章
[Wu, Panyun]的文章
必应学术
必应学术中相似的文章
[Chen, Chenyang]的文章
[Luo, Fei]的文章
[Wu, Panyun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。